Atlas Trials

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

Clinical trial NCT02939547 · COMPLETED

Trial details

NCT number
NCT02939547
Sponsor
Cyclo Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Niemann-Pick Disease, Type C1
Start date
2017-10-11
Primary completion
2020-02-10
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.